Receipt of Fluoroquinolone Prophylaxis is not Associated With Development of Vancomycin-Resistant <i>Enterococcus</i> Colonization During Pediatric Hematopoietic Cell Transplantation
Fluoroquinolones are used to prevent bloodstream infections in pediatric hematopoietic cell transplant (HCT) recipients. We performed a retrospective cohort study in 799 pediatric HCT patients to evaluate the association between fluoroquinolone prophylaxis and VRE colonization. Propensity score analyses were performed. Fluoroquinolone prophylaxis was not associated with VRE colonization.
Authors
- Felicia Scaggs Huang (ORCID: https://orcid.org/0000-0002-3944-6208)
- Michael Grimley (ORCID: https://orcid.org/0000-0003-2056-5167)
- W Otto (ORCID: https://orcid.org/0000-0001-7959-1445)
- Catherine R Murphy
- Cameron Griffin
- Lara Danziger‐Isakov (ORCID: https://orcid.org/0000-0002-5691-5221)
- Hilary Miller‐Handley (ORCID: https://orcid.org/0000-0001-6805-6025)
- Chunyan Liu (ORCID: https://orcid.org/0000-0002-9194-5290)
- Joshua Courter
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Journal of the Pediatric Infectious Diseases Society
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1093/jpids/piaf010
- Citations
- 1
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 1.40